+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fluorescein Angiography Market Size, Share & Trends Analysis Report By Type (Traditional Fluorescein Angiography), By Application (Age-related Macular Degeneration), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032424
Description Jump to:
The global fluorescein angiography market size is expected to reach USD 1.39 billion by the end of 2030, expanding at a CAGR of 8.5% from 2025 to 2030. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Fluorescein Angiography Market Report Highlights

  • Traditional fluorescein angiography dominated the market and accounted for the largest revenue share of 56.4% in 2024, attributed to the rising incidence of eye diseases, particularly diabetic retinopathy and age-related macular degeneration.
  • The age-related macular degeneration (AMD) application held the dominant position in the market, with the largest revenue share of 32.6% in 2024, owing to the increasing prevalence of this condition among the aging population.
  • The hospitals and clinics segment led the market and accounted for the largest revenue share of 63.9% in 2024 attributed to the increasing prevalence of eye diseases, particularly among the aging population.
  • The fluorescein angiography market in North America dominated the global market and accounted for the largest revenue share of 36.4% in 2024 attributed to the high prevalence of eye diseases, particularly diabetic retinopathy, which affects millions of individuals.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Fluorescein Angiography Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Fluorescein Angiography Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Traditional Fluorescein Angiography (FA)
4.4.1. Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
4.5. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA
4.5.1. Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)
Chapter 5. Fluorescein Angiography Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Age-related Macular Degeneration (AMD)
5.4.1. Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
5.5. Diabetic Retinopathy
5.5.1. Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
5.6. Retinal Vein Occlusion
5.6.1. Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
5.7. Uveitis and Retinal Vasculitis
5.7.1. Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
5.8. Choroidal Tumors
5.8.1. Choroidal Tumors Market, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Fluorescein Angiography Market: End Use Business Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals and Clinics
6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Fluorescein Angiography Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Insights
7.4.2.4. U.S. Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Insights
7.4.3.4. Canada Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Insights
7.4.4.4. Mexico Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Insights
7.5.2.4. UK Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Insights
7.5.3.4. Germany Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Insights
7.5.4.4. France Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Insights
7.5.5.4. Italy Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework
7.5.6.3. Competitive Insights
7.5.6.4. Spain Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework
7.5.7.3. Competitive Insights
7.5.7.4. Norway Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework
7.5.8.3. Competitive Insights
7.5.8.4. Denmark Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Sweden
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory Framework
7.5.9.3. Competitive Insights
7.5.9.4. Sweden Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Insights
7.6.2.4. Japan Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Insights
7.6.3.4. China Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Insights
7.6.4.4. India Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Insights
7.6.5.4. South Korea Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Insights
7.6.6.4. Australia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory Framework
7.6.7.3. Competitive Insights
7.6.7.4. Thailand Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework
7.7.2.3. Competitive Insights
7.7.2.4. Brazil Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework
7.7.3.3. Competitive Insights
7.7.3.4. Argentina Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework
7.8.2.3. Competitive Insights
7.8.2.4. South Africa Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework
7.8.3.3. Competitive Insights
7.8.3.4. Saudi Arabia Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework
7.8.4.3. Competitive Insights
7.8.4.4. UAE Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Framework
7.8.5.3. Competitive Insights
7.8.5.4. Kuwait Fluorescein Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Carl Zeiss Meditec, Inc.
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Type Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. NIDEK Co., Ltd.
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Type Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Kowa Company Ltd.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Type Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Topcon Medical Systems, Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Type Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Optomed Oy (Ltd.)
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Type Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. CenterVue SpA
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Type Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Canon, Inc.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Type Benchmarking
8.5.7.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Fluorescein Angiography Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 5 Global Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 7 North America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 9 North America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 10 North America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 12 U.S. Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 15 Canada Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 16 Canada Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 17 Mexico Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 18 Mexico Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 19 Mexico Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 20 Europe Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 22 Europe Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 23 Europe Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 24 UK Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 25 UK Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 26 UK Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 27 Germany Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 28 Germany Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 29 Germany Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 30 France Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 31 France Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 32 France Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 33 Italy Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 34 Italy Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 35 Italy Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 36 Spain Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 37 Spain Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 38 Spain Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 39 Norway Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 40 Norway Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 41 Norway Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 42 Denmark Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 43 Denmark Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 44 Denmark Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Sweden Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 46 Sweden Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 47 Sweden Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 53 Japan Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 54 Japan Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 55 China Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 56 China Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 57 China Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 58 India Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 59 India Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 60 India Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Australia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 62 Australia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 63 Australia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 64 South Korea Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 65 South Korea Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 66 South Korea Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 68 Thailand Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 69 Thailand Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 72 Latin America Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 73 Latin America Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 74 Brazil Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 75 Brazil Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 76 Brazil Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 77 Argentina Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 78 Argentina Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 79 Argentina Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Fluorescein Angiography Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 84 South Africa Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 85 South Africa Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 86 South Africa Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 90 UAE Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 91 UAE Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 92 UAE Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
Table 93 Kuwait Fluorescein Angiography Market, by Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Fluorescein Angiography Market, by Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Fluorescein Angiography Market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Fluorescein Angiography Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 Market Formulation & Validation
Fig. 8 Market Snapshot
Fig. 9 Type, Application Outlook (USD Million)
Fig. 10 End Use Outlook (USD Million)
Fig. 11 Competitive Landscape
Fig. 12 Fluorescein Angiography Market Dynamics
Fig. 13 Fluorescein Angiography Market: Porter’s Five Forces Analysis
Fig. 14 Fluorescein Angiography Market: PESTLE analysis
Fig. 15 Fluorescein Angiography Market: Type Segment Dashboard
Fig. 16 Fluorescein Angiography Market: Type Market Share Analysis, 2024 & 2030
Fig. 17 Traditional Fluorescein Angiography (FA) Market, 2018 - 2030 (USD Million)
Fig. 18 Confocal Scanning Laser Ophthalmoscopy (cSLO) FA Market, 2018 - 2030 (USD Million)
Fig. 19 Fluorescein Angiography Market: Application Segment Dashboard
Fig. 20 Fluorescein Angiography Market: Application Market Share Analysis, 2024 & 2030
Fig. 21 Age-related Macular Degeneration (AMD) Market, 2018 - 2030 (USD Million)
Fig. 22 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
Fig. 23 Retinal Vein Occlusion Market, 2018 - 2030 (USD Million)
Fig. 24 Uveitis and Retinal Vasculitis Market, 2018 - 2030 (USD Million)
Fig. 25 Choroidal Tumors Market, 2018 - 2030 (USD Million)
Fig. 26 Others Market, 2018 - 2030 (USD Million)
Fig. 27 Fluorescein Angiography Market: End Use Segment Dashboard
Fig. 28 Fluorescein Angiography Market: End Use Market Share Analysis, 2024 & 2030
Fig. 29 Hospitals and Clinics Market, 2018 - 2030 (USD Million)
Fig. 30 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
Fig. 31 Others Market, 2018 - 2030 (USD Million)
Fig. 32 Fluorescein Angiography Market Revenue, By Region
Fig. 33 Regional Marketplace: Key Takeaways
Fig. 34 Regional Marketplace: Key Takeaways
Fig. 35 North America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 36 U.S. Country Dynamics
Fig. 37 U.S. Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Country Dynamics
Fig. 39 Canada Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 40 Mexico Country Dynamics
Fig. 41 Mexico Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 42 Europe Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 43 UK Country Dynamics
Fig. 44 UK Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 45 Germany Country Dynamics
Fig. 46 Germany Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 47 France Country Dynamics
Fig. 48 France Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 49 Italy Country Dynamics
Fig. 50 Italy Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 51 Spain Country Dynamics
Fig. 52 Spain Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 53 Norway Country Dynamics
Fig. 54 Norway Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 55 Sweden Country Dynamics
Fig. 56 Sweden Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 57 Denmark Country Dynamics
Fig. 58 Denmark Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 59 Asia Pacific Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 60 Japan Country Dynamics
Fig. 61 Japan Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 62 China Country Dynamics
Fig. 63 China Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 64 India Country Dynamics
Fig. 65 India Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 66 Australia Country Dynamics
Fig. 67 Australia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 68 South Korea Country Dynamics
Fig. 69 South Korea Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 70 Thailand Country Dynamics
Fig. 71 Thailand Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 72 Latin America Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 73 Brazil Country Dynamics
Fig. 74 Brazil Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 75 Argentina Country Dynamics
Fig. 76 Argentina Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 77 MEA Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 78 South Africa Country Dynamics
Fig. 79 South Africa Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 80 Saudi Arabia Country Dynamics
Fig. 81 Saudi Arabia Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 82 UAE Country Dynamics
Fig. 83 UAE Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 84 Kuwait Key Country Dynamicss
Fig. 85 Kuwait Fluorescein Angiography Market, 2018 - 2030 (USD Million)
Fig. 86 Company Categorization
Fig. 87 Company Market Position Analysis
Fig. 88 Strategic Framework

Companies Mentioned

  • Carl Zeiss Meditec, Inc.
  • NIDEK Co., Ltd.
  • Kowa Company Ltd.
  • Topcon Medical Systems, Inc.
  • Optomed Oy (Ltd.)
  • CenterVue SpA
  • Canon, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 0.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.39 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Fluorescein Angiography Market by Product, Technology, Application - Global Forecast 2025-2030 - Product Image

Fluorescein Angiography Market by Product, Technology, Application - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Global Fluorescein Angiography Market by Type, by Application, by End-User, and By Region - Product Image

Global Fluorescein Angiography Market by Type, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Angiography Equipment Market by Product Type, Technology, Application, End User - Global Forecast 2025-2030 - Product Image

Angiography Equipment Market by Product Type, Technology, Application, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Coronary Angiography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Angiography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Angiography Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Angiography Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.